Tori Rodriguez, MA, LPC, AHC

Drs O’Shea and Gandhi comment on the benefits and barriers of rapid antiretroviral therapy for HIV infection among patients in emergency departments.

Health care shortages in rural areas in the United States affect an estimated 60 million people.

Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.

As the opioid epidemic worsens, rates of drug use-related infective endocarditis and associated procedures have grown substantially.

Lisa Winston, MD; Ryan Miller, DO; and Neha Nanda, MD, discuss measures to reduce the spread of health care-associated Clostridioides difficile infection.

Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.

In this Q&A, Drs Serota and Thakarar discuss the dual subspecialty of infectious disease and addiction medicine and its role in combating the ongoing opioid epidemic.

Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.

In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.

A significant number of cases of post-COVID-19 myocarditis have been reported.

To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.

Recent studies have shown an increase in depression and suicidality in transgender youth. To learn more about the mental health challenges affecting transgender youth and how clinicians can better support these patients, we interviewed Jason V. Lambrese, MD, staff child and adolescent psychiatrist at Cleveland Clinic’s Lakewood Family Health Canter in Lakewood, Ohio, and Ralph Vetters, MD, MPH, pediatrician and site medical director at the Sidney Borum Jr. Health Center, a program of Fenway Health in Boston.

With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.

In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH.

An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.

In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.

Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.

Monisha Sharma, PhD, and Charlene Dewey, MD, provide insight into the current landscape that leads to physician burnout and the next steps to combat it.

An overview of the risk for infections during targeted and biological therapies in rheumatoid arthritis and psoriatic arthritis.

While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.

Numerous reports have indicated gastrointestinal, cardiovascular, and neurologic manifestations, in addition to the noted respiratory effects, in patients with COVID-19, and up to 50% of patients with COVID-19 may experience hepatic manifestations.

Due to innate and adaptive immune alterations and the risk for nosocomial infection from exposure to potentially infected blood-borne sources, patients with end-stage renal disease (ESRD) have an elevated risk of contracting viral infections.

The estimated US prevalence of HBV is roughly 2% in the general population and 0.7% to 0.9% among pregnant women.

The PA-I38 mutations were noted frequently in influenza A/H3N2 viruses compared with A/H1N1pdm or influenza B viruses.

In the United States, approximately 3.5 million people are infected with the hepatitis C virus, which contributes to psychological and cognitive disorders for about half of all patients.

Leishmaniasis is a neglected tropical disease that is transmitted by phlebotomine sand flies infected with Leishmania parasites.

Managing the risk for infection is one of the primary tasks in optimizing outcomes for solid organ transplant recipients.

The review authors used existing evidence to recommend a new model of palliative care integration in patients with hepatocellular carcinoma.